A new drug to treat vascular dementia
A Novel-designed sulfonylurea compound for Vascular Dementia Therapy
This study is testing a new medication that could help reduce inflammation in the brain for people with vascular dementia, with the hope of slowing down the disease and improving thinking skills.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10726896 on NIH RePORTER |
What this research studies
This research focuses on developing a novel sulfonylurea compound aimed at reducing inflammation associated with vascular dementia. By targeting a specific protein involved in inflammation, the study seeks to slow the progression of the disease and enhance cognitive functions. The approach involves testing the new compound in mouse models to understand its effects on inflammation and cognitive health. If successful, this could lead to a new treatment option for patients suffering from vascular dementia.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with vascular dementia or related cognitive impairments.
Not a fit: Patients with other forms of dementia, such as frontotemporal dementia or those without any cognitive impairment, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new effective treatment option that improves cognitive function in patients with vascular dementia.
How similar studies have performed: Previous research has shown promise in targeting inflammation for treating neurodegenerative disorders, suggesting that this approach could be effective.
Where this research is happening
Houston, United States
- University of Houston — Houston, United States (Active)
Researchers
- Principal investigator: Hao, Jiukuan — University of Houston
- Study coordinator: Hao, Jiukuan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.